IBDEI0PB ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12408,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,12409,0)
 ;;=286.0^^70^757^1
 ;;^UTILITY(U,$J,358.3,12409,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12409,1,1,0)
 ;;=1^286.0
 ;;^UTILITY(U,$J,358.3,12409,1,8,0)
 ;;=8^Congenital Factor VIII
 ;;^UTILITY(U,$J,358.3,12409,2)
 ;;=^27454
 ;;^UTILITY(U,$J,358.3,12410,0)
 ;;=275.03^^70^757^3
 ;;^UTILITY(U,$J,358.3,12410,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12410,1,1,0)
 ;;=1^275.03
 ;;^UTILITY(U,$J,358.3,12410,1,8,0)
 ;;=8^Hemochromatosis NEC
 ;;^UTILITY(U,$J,358.3,12410,2)
 ;;=^339604
 ;;^UTILITY(U,$J,358.3,12411,0)
 ;;=205.00^^70^758^1
 ;;^UTILITY(U,$J,358.3,12411,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12411,1,1,0)
 ;;=1^205.00
 ;;^UTILITY(U,$J,358.3,12411,1,8,0)
 ;;=8^A M L, W/O Remission
 ;;^UTILITY(U,$J,358.3,12411,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,12412,0)
 ;;=205.01^^70^758^2
 ;;^UTILITY(U,$J,358.3,12412,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12412,1,1,0)
 ;;=1^205.01
 ;;^UTILITY(U,$J,358.3,12412,1,8,0)
 ;;=8^A M L,In Remission
 ;;^UTILITY(U,$J,358.3,12412,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,12413,0)
 ;;=205.10^^70^758^4
 ;;^UTILITY(U,$J,358.3,12413,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12413,1,1,0)
 ;;=1^205.10
 ;;^UTILITY(U,$J,358.3,12413,1,8,0)
 ;;=8^C M L,W/O Remission
 ;;^UTILITY(U,$J,358.3,12413,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,12414,0)
 ;;=205.11^^70^758^3
 ;;^UTILITY(U,$J,358.3,12414,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12414,1,1,0)
 ;;=1^205.11
 ;;^UTILITY(U,$J,358.3,12414,1,8,0)
 ;;=8^C M L,In Remission
 ;;^UTILITY(U,$J,358.3,12414,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,12415,0)
 ;;=289.0^^70^758^7
 ;;^UTILITY(U,$J,358.3,12415,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12415,1,1,0)
 ;;=1^289.0
 ;;^UTILITY(U,$J,358.3,12415,1,8,0)
 ;;=8^Secondary Polycythemia
 ;;^UTILITY(U,$J,358.3,12415,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,12416,0)
 ;;=238.4^^70^758^6
 ;;^UTILITY(U,$J,358.3,12416,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12416,1,1,0)
 ;;=1^238.4
 ;;^UTILITY(U,$J,358.3,12416,1,8,0)
 ;;=8^Polycythemia Rubra Vera
 ;;^UTILITY(U,$J,358.3,12416,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,12417,0)
 ;;=288.9^^70^758^9
 ;;^UTILITY(U,$J,358.3,12417,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12417,1,1,0)
 ;;=1^288.9
 ;;^UTILITY(U,$J,358.3,12417,1,8,0)
 ;;=8^Unspecified Dis Of W B C
 ;;^UTILITY(U,$J,358.3,12417,2)
 ;;=^267993
 ;;^UTILITY(U,$J,358.3,12418,0)
 ;;=289.81^^70^758^8
 ;;^UTILITY(U,$J,358.3,12418,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12418,1,1,0)
 ;;=1^289.81
 ;;^UTILITY(U,$J,358.3,12418,1,8,0)
 ;;=8^Unspecified Blood Diseases
 ;;^UTILITY(U,$J,358.3,12418,2)
 ;;=^329886
 ;;^UTILITY(U,$J,358.3,12419,0)
 ;;=238.75^^70^758^5
 ;;^UTILITY(U,$J,358.3,12419,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12419,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,12419,1,8,0)
 ;;=8^Myelodysplastic Syndrome
 ;;^UTILITY(U,$J,358.3,12419,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,12420,0)
 ;;=204.00^^70^759^2
 ;;^UTILITY(U,$J,358.3,12420,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12420,1,1,0)
 ;;=1^204.00
 ;;^UTILITY(U,$J,358.3,12420,1,8,0)
 ;;=8^A L L,W/O Remission
 ;;^UTILITY(U,$J,358.3,12420,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,12421,0)
 ;;=204.01^^70^759^1
 ;;^UTILITY(U,$J,358.3,12421,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12421,1,1,0)
 ;;=1^204.01
 ;;^UTILITY(U,$J,358.3,12421,1,8,0)
 ;;=8^A L L, In Remission
 ;;^UTILITY(U,$J,358.3,12421,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,12422,0)
 ;;=204.10^^70^759^5
 ;;^UTILITY(U,$J,358.3,12422,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12422,1,1,0)
 ;;=1^204.10
